Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Divya Chaudhary

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
FEBS Letters|September 11, 2004
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCthetaKelly-Ann Sheppard, Lori J Fitz, Julie M Lee, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCtheta inhibitorsDiane H Boschelli, Joan Subrath, Chuansheng Niu, et al.
The Journal of Biological Chemistry|September 15, 2004
Catalytic domain crystal structure of protein kinase C-theta (PKCtheta)Zhang-Bao Xu, Divya Chaudhary, Stephane Olland, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCtheta inhibitors: part IIAmar S Prashad, Daniel Wang, Joan Subrath, et al.
British Journal of Haematology|December 12, 2018
MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLLMa Reina Improgo, Bethany Tesar, Josephine L Klitgaard, et al.
BMC Health Services Research|September 8, 2022
Development of a cost of illness inventory questionnaire for children with autism spectrum disorder in South AsiaDivya Chaudhary, Bhargav Bhat, Gemma E Shields, et al.
Journal of Medicinal Chemistry|September 12, 2008
Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitorsDerek C Cole, Magda Asselin, Agnes Brennan, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
FEBS Letters|September 11, 2004
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCthetaKelly-Ann Sheppard, Lori J Fitz, Julie M Lee, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCtheta inhibitorsDiane H Boschelli, Joan Subrath, Chuansheng Niu, et al.
The Journal of Biological Chemistry|September 15, 2004
Catalytic domain crystal structure of protein kinase C-theta (PKCtheta)Zhang-Bao Xu, Divya Chaudhary, Stephane Olland, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCtheta inhibitors: part IIAmar S Prashad, Daniel Wang, Joan Subrath, et al.
British Journal of Haematology|December 12, 2018
MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLLMa Reina Improgo, Bethany Tesar, Josephine L Klitgaard, et al.
BMC Health Services Research|September 8, 2022
Development of a cost of illness inventory questionnaire for children with autism spectrum disorder in South AsiaDivya Chaudhary, Bhargav Bhat, Gemma E Shields, et al.
Journal of Medicinal Chemistry|September 12, 2008
Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitorsDerek C Cole, Magda Asselin, Agnes Brennan, et al.
Pageof 4